Zoetis to buy Abaxis for $1.9 bln in cash


May 16 (Reuters) - Animal health company Zoetis Inc said on Wednesday it would buy Abaxis Inc, a maker of veterinary diagnostic instruments, for about $1.9 billion in cash.

Zoetis has offered Abaxis$83 per share, a premium of 15.7 percent to its Tuesday's close.




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of NASDAQ, Inc.